The VITAL study and overall pooled analysis with the VIPS non-invasive stroke detection device

IntroductionEffective triage of patients with emergent large vessel occlusion (ELVO) to endovascular therapy capable centers may decrease time to treatment and improve outcome for these patients. Here we performed a derivation study to evaluate the accuracy of a portable, non-invasive, and easy to u...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurointerventional surgery Vol. 10; no. 11; pp. 1079 - 1084
Main Authors Kellner, Christopher P, Sauvageau, Eric, Snyder, Kenneth V, Fargen, Kyle M, Arthur, Adam S, Turner, Raymond D, Alexandrov, Andrei V
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.11.2018
BMJ Publishing Group
SeriesOriginal research
Subjects
Online AccessGet full text
ISSN1759-8478
1759-8486
1759-8486
DOI10.1136/neurintsurg-2017-013690

Cover

Loading…
More Information
Summary:IntroductionEffective triage of patients with emergent large vessel occlusion (ELVO) to endovascular therapy capable centers may decrease time to treatment and improve outcome for these patients. Here we performed a derivation study to evaluate the accuracy of a portable, non-invasive, and easy to use severe stroke detector.MethodsThe volumetric impedance phase shift spectroscopy (VIPS) device was used to assign a bioimpedance asymmetry score to 248 subjects across three cohorts, including 41 subjects presenting as acute stroke codes at a major comprehensive stroke center (CSC), 79 healthy volunteers, and 128 patients presenting to CSCs with a wide variety of brain pathology including additional stroke codes. Diagnostic parameters were calculated for the ability of the device to discern (1) severe stroke from minor stroke and (2) severe stroke from all other subjects. Patients with intracranial hardware were excluded from the analysis.ResultsThe VIPS device was able to differentiate severe stroke from minor strokes with a sensitivity of 93% (95% CI 83 to 98), specificity of 92% (95% CI 75 to 99), and an area under the curve (AUC) of 0.93 (95% CI 0.85 to 0.97). The device was able to differentiate severe stroke from all other subjects with a sensitivity of 93% (95% CI 83 to 98), specificity of 87% (95% CI 81 to 92), and an AUC of 0.95 (95% CI 0.89 to 0.96).ConclusionThe VIPS device is a portable, non-invasive, and easy to use tool that may aid in the detection of severe stroke, including ELVO, with a sensitivity of 93% and specificity of 92% in this derivation study. This device has the potential to improve the triage of patients suffering severe stroke.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1759-8478
1759-8486
1759-8486
DOI:10.1136/neurintsurg-2017-013690